Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
NewsOct 23, 2026
- Markets
- MasterclassNEW
- Portfolio X-ray
- StockIQNEW
- My Watchlist
- News
- Stock Recos
- Screeners
- AI Chart PatternsNEW
- ETMarkets GPT
US Stocks
- Sector: Pharmaceuticals
- Industry: Pharma - Indian
OneSource Specialty Pharma Share Price
1,610.0026.41 (1.67%)
Volume: 969
LiveLast Updated On: 05 Nov, 2026, 09:09 AM IST
- Open:1,610.00
- High:1,610.00
- Low:1,610.00
Loading...
Research insights
Stock Recommendations
Potential
Upside*1 Year
Target
STRONG BUY
Mean Recos by
4 Analysts
Stock Reports Plus
/10
Stock Score
View Report
| Earnings | |
| Fundamentals | |
| Relative Valuation | |
| Risk | |
| Price Momentum |
No Rating (NR)
Negative
Neutral
Positive
* Investments in securities are subject to market risks. These are indicative and should not be interpreted as investment advice or guaranteed returns.
Key Metrics
PE RatioThis is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. | -11,202.80 | ||||||||||
EPS - TTMEarnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. | -0.14 | ||||||||||
MCapMCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. | 18,159.74 | ||||||||||
Sectoral MCap RankThis is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned. | 31 | ||||||||||
PB RatioPrice to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. | 3.11 | ||||||||||
Dividend YieldDividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors. | 0.00 | ||||||||||
Face ValueFace value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value. | 1.00 | ||||||||||
Beta
| - | ||||||||||
VWAPVolume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. | 1,610.00 | ||||||||||
52W H/LThis represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. | 1,917.80 / 1,057.00 |
OneSource Specialty Share Price Insights
- Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)
- Company has spent 8.59% of its operating revenues towards interest expenses and 17.04% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
- White Spinning Top was formed for OneSource Specialty
OneSource Specialty Pharma Ltd. share price moved up by 1.67% from its previous close of Rs 1,583.60. OneSource Specialty Pharma Ltd. stock last traded price is 1,610.00
Share Price Value Today/Current/Last 1,610.00 Previous Day 1,583.60
OneSource Specialty Share Price Returns
| 1 Day | 1.67% |
| 1 Week | 2.57% |
| 1 Month | 8.18% |
| 3 Months | 3.62% |
| 1 Year | -12.19% |
| 3 Years | N.A. |
| 5 Years | N.A. |
ET Stock ScreenersTop Score Companies
Check whether OneSource Specialty belongs to analysts' top-rated companies list?
View Stock ScreenersNews & Analysis
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Newspaper Publication
Share Recommendations
Recent Recos
Current
Mean Recos by 4 Analysts
STRONG BUY
Strong SellSellHoldBuyStrong Buy
Analyst Trends
| Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 1 | 1 |
| Hold | - | - | - | - |
| Sell | - | - | 1 | 1 |
| Strong Sell | - | - | - | - |
| # Analysts | 4 | 4 | 4 | 4 |
Financials
Insights
| | SEPT 2026 | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|---|---|
| Total Income | 517.20 | 452.83 | 430.31 | 294.97 | 378.80 |
| Total Income Growth (%) | 14.22 | 5.23 | 45.89 | -22.13 | 13.91 |
| Total Expenses | 429.77 | 401.72 | 408.09 | 349.75 | 339.10 |
| Total Expenses Growth (%) | 6.98 | -1.56 | 16.68 | 3.14 | 9.58 |
| EBIT | 87.43 | 51.10 | 22.22 | -54.78 | 39.70 |
| EBIT Growth (%) | 71.08 | 129.98 | - | -237.97 | 72.04 |
| Profit after Tax (PAT) | 57.48 | 25.00 | 4.60 | -88.70 | 10.49 |
| PAT Growth (%) | 129.96 | 443.77 | - | -945.96 | - |
| EBIT Margin (%) | 16.90 | 11.29 | 5.16 | -18.57 | 10.48 |
| Net Profit Margin (%) | 11.11 | 5.52 | 1.07 | -30.07 | 2.77 |
| Basic EPS () | 5.01 | 2.18 | 0.40 | -7.74 | 0.92 |
All figures in Rs Cr, unless mentioned otherwise
View DetailsShare Price Forecast
Get multiple analysts' prediction on OneSource Specialty
- High, low, medium predictions for Price
- Upcoming predictions for Revenue
- Details about company earnings
Technicals
Peer Comparison
MF Ownership
566.31
Amount Invested (in Cr.)
2.86%
% of AUM
0.00
% Change (MoM basis)
165.85
Amount Invested (in Cr.)
3.39%
% of AUM
0.00
% Change (MoM basis)
363.85
Amount Invested (in Cr.)
2.71%
% of AUM
0.00
% Change (MoM basis)
Corporate Actions
| Meeting Date | Announced on | Purpose | Details |
|---|---|---|---|
| Oct 27, 2026 | Oct 21, 2026 | Board Meeting | Quarterly Results |
| Sep 23, 2026 | Sep 1, 2026 | AGM | General Meeting |
| Jul 24, 2026 | Jul 20, 2026 | Board Meeting | Quarterly Results |
| May 13, 2026 | May 7, 2026 | Board Meeting | Audited Results |
| Jan 23, 2026 | Jan 19, 2026 | Board Meeting | Quarterly Results |
| Nov 11, 2025 | Nov 6, 2025 | Board Meeting | Quarterly Results |
| Sep 22, 2025 | Sep 1, 2025 | AGM | General Meeting |
| Aug 1, 2025 | Jun 30, 2025 | POM | General Meeting |
| May 27, 2025 | Apr 25, 2025 | POM | General Meeting |
About OneSource Specialty
OneSource Specialty Pharma Ltd., incorporated in the year 2007, is a Small Cap company (having a market cap of Rs 18,159.74 Crore) operating in Pharmaceuticals sector.
OneSource Specialty Pharma Ltd. key Products/Revenue Segments include Sale of Services and Pharmaceuticals for the year ending 31-Mar-2026.
AP
Arun Kumar Pillai
Chairperson & Non Executive DirectorNS
Neeraj Sharma
Managing Director & CEOBS
Bharat Shah
Non Executive DirectorCA
Claudio Albrecht
Ind. Non-Executive DirectorIndustry
Key Indices Listed On
Nifty Smallcap 100, Nifty 500, BSE 500, + 18 more
Address
Unit No. 902, Cyber One,, Plot No - 4 & 6, Sector 30A, Vashi,, Navi Mumbai, Sanpada,, Thane, Maharashtra, 400703
More Details
- OneSource Specialty Pharma Ltd. Chairman's Speech
- OneSource Specialty Pharma Ltd. Company History
- OneSource Specialty Pharma Ltd. Directors Report
- OneSource Specialty Pharma Ltd. Background information
- OneSource Specialty Pharma Ltd. Company Management
- OneSource Specialty Pharma Ltd. Listing Information
- OneSource Specialty Pharma Ltd. Finished Products
Trending in Markets
Top Gainers
Top Losers
OneSource Specialty Quick Links
Equity Quick Links
More from Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.
